Smurf1-IN-A01
CAS No. 1007647-73-5
Smurf1-IN-A01 ( A01 )
Catalog No. M23212 CAS No. 1007647-73-5
Smurf1-IN-A01 is a ubiquitin ligase Smad ubiquitination regulatory factor-1 inhibitor (kd: 3.664 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 41 | In Stock |
|
5MG | 65 | In Stock |
|
10MG | 110 | In Stock |
|
25MG | 222 | In Stock |
|
50MG | 356 | In Stock |
|
100MG | 530 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSmurf1-IN-A01
-
NoteResearch use only, not for human use.
-
Brief DescriptionSmurf1-IN-A01 is a ubiquitin ligase Smad ubiquitination regulatory factor-1 inhibitor (kd: 3.664 nM).
-
DescriptionSmurf1-IN-A01 is a ubiquitin ligase Smad ubiquitination regulatory factor-1 inhibitor (kd: 3.664 nM). It increases BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradation.
-
SynonymsA01
-
PathwayOthers
-
TargetOther Targets
-
RecptorSmurf1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1007647-73-5
-
Formula Weight512.9
-
Molecular FormulaC22H20ClF3N4O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO:62.5 mg/mL (121.85 mM; Need ultrasonic)
-
SMILESCC1=CC=NN1C2=CC=C(C=C2)C(=O)N3CCN(CC3)S(=O)(=O)C4=CC(=C(C=C4)Cl)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cao Y, et al. Selective small molecule compounds increase BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradation. Sci Rep. 2014 May 14;4:4965.
molnova catalog
related products
-
3-(2-Glucosyloxy-4-m...
2-O-beta-d-Glucosyloxy-4-methoxybenzenepropanoic acid[3-(2-Glucosyloxy-4-methoxyphenyl)propanoic acid] exhibits glutathione S-transferase (GST) inhibitory and antifungal activities.
-
Betulinaldehyde
Betulinaldehyde has the inhibition of Saccharomyces sp and alpha-glucosidase.
-
Visnagin
Visnagin has acute hypotensive anti-inflammatory and neuroprotective effects it protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase.